135 related articles for article (PubMed ID: 33399347)
1. Subcutaneous implantable cardioverter-defibrillator and left ventricular assist devices for refractory heart failure: attention to possible interference.
Migliore F; Giacomin E; Del Monte A; Tarzia V; Bottio T; Iliceto S; Gerosa G
J Cardiovasc Med (Hagerstown); 2021 Oct; 22(10):795-796. PubMed ID: 33399347
[No Abstract] [Full Text] [Related]
2. Electromagnetic interference from left ventricular assist devices in patients with subcutaneous implantable cardioverter-defibrillators.
Ishida Y; Payne JE; Field ME; Gold MR
J Cardiovasc Electrophysiol; 2020 May; 31(5):1195-1201. PubMed ID: 32128931
[TBL] [Abstract][Full Text] [Related]
3. Subcutaneous implantable cardioverter-defibrillator and left ventricular assist devices for refractory heart failure: attention to possible interference.
Bonnì E; Coppola G
J Cardiovasc Med (Hagerstown); 2021 Dec; 22(12):e52. PubMed ID: 34747932
[No Abstract] [Full Text] [Related]
4. Successful implantation of subcutaneous implantable cardioverter-defibrillator in a patient with severe pectus excavatum.
Karvouni E; Zografos T; Winter J; Katritsis D
Europace; 2018 Nov; 20(11):1848. PubMed ID: 30388218
[No Abstract] [Full Text] [Related]
5. Troubleshooting electromagnetic interference in a patient with centrifugal flow left ventricular assist device and subcutaneous implantable cardioverter defibrillator.
Ahmed AS; Patel PJ; Bagga S; Gilge JL; Schleeter T; Lakhani BA; Ravichandran AK; Donnelley S; Allavatam V; Prystowsky EN; Padanilam BJ
J Cardiovasc Electrophysiol; 2018 Mar; 29(3):477-481. PubMed ID: 29364552
[TBL] [Abstract][Full Text] [Related]
6. Use of an automatic internal defibrillator to induce and maintain ventricular fibrillation during left ventricular assist device pump exchange.
Levin MA; Anyanwu AC; Eggert CA; Mittnacht AJ
J Thorac Cardiovasc Surg; 2014 Mar; 147(3):e17-8. PubMed ID: 24290714
[No Abstract] [Full Text] [Related]
7. Circumventing a left ventricular assist device and implantable cardioverter defibrillator interaction: an alternative method of shielding.
Guise KD; Franconame F; Chung EH
Europace; 2013 Dec; 15(12):1689. PubMed ID: 23608031
[No Abstract] [Full Text] [Related]
8. Implantable cardioverter-defibrillator lead revision following left ventricular assist device implantation.
Black-Maier E; Lewis RK; Rehorn M; Loungani R; Friedman DJ; Frazier-Mills C; Jackson KP; Atwater BD; Milano CA; Schroder JN; Pokorney SD; Piccini JP
J Cardiovasc Electrophysiol; 2020 Jun; 31(6):1509-1518. PubMed ID: 32275340
[TBL] [Abstract][Full Text] [Related]
9. T wave oversensing and low percentage of biventricular pacing in cardiac resynchronization therapy.
Lezcano AO; Aracama JM; Ayestaran VU; Urra FG
Cardiol J; 2009; 16(6):580-1. PubMed ID: 19950098
[TBL] [Abstract][Full Text] [Related]
10. Role of defibrillation threshold testing in the contemporary defibrillator patient population.
Vischer AS; Sticherling C; Kühne MS; Osswald S; Schaer BA
J Cardiovasc Electrophysiol; 2013 Apr; 24(4):437-41. PubMed ID: 23210803
[TBL] [Abstract][Full Text] [Related]
11. Subcutaneous implantable cardioverter-defibrillator implantation in a patient with a left ventricular assist device already in place.
Gupta A; Subzposh F; Hankins SR; Kutalek SP
Tex Heart Inst J; 2015 Apr; 42(2):140-3. PubMed ID: 25873825
[TBL] [Abstract][Full Text] [Related]
12. Therapy optimization in patients with heart failure: the role of the wearable cardioverter-defibrillator in a real-world setting.
Röger S; Rosenkaimer SL; Hohneck A; Lang S; El-Battrawy I; Rudic B; Tülümen E; Stach K; Kuschyk J; Akin I; Borggrefe M
BMC Cardiovasc Disord; 2018 Mar; 18(1):52. PubMed ID: 29544442
[TBL] [Abstract][Full Text] [Related]
13. Implantation of a right ventricular implantable cardioverter-defibrillator lead in the right ventricular outflow tract in a patient with Ebstein anomaly and right ventricular lead dislocation.
Pecha S; Yildirim Y; Hahnel F; Reichenspurner H; Aydin MA
Thorac Cardiovasc Surg; 2014 Apr; 62(3):253-4. PubMed ID: 23258759
[TBL] [Abstract][Full Text] [Related]
14. Completely epicardial implantation of a cardiac resynchronization therapy defibrillator using a minimal invasive approach.
Starck CT; Mayer K; Hürlimann D; Steffel J; Falk V
Thorac Cardiovasc Surg; 2014 Feb; 62(1):70-2. PubMed ID: 23225506
[TBL] [Abstract][Full Text] [Related]
15. Role of implantable cardioverter-defibrillators in patients with continuous flow ventricular assist devices.
Boilson BA; Friedman PA
Circ Arrhythm Electrophysiol; 2013 Aug; 6(4):663-5. PubMed ID: 23962858
[No Abstract] [Full Text] [Related]
16. Unusual "ratchet syndrome": spontaneous lead retraction after a generator exchange.
Ejima K; Shoda M; Yashiro B; Yoshida K; Nuki T; Kato K; Manaka T; Hagiwara N
Heart Vessels; 2014 Jul; 29(4):550-3. PubMed ID: 23846318
[TBL] [Abstract][Full Text] [Related]
17. Who should receive the subcutaneous implanted defibrillator?: The subcutaneous implantable cardioverter defibrillator (ICD) should be considered in all ICD patients who do not require pacing.
Poole JE; Gold MR
Circ Arrhythm Electrophysiol; 2013 Dec; 6(6):1236-44; discussion 1244-5. PubMed ID: 24347599
[No Abstract] [Full Text] [Related]
18. iPad2(R) use in patients with implantable cardioverter defibrillators causes electromagnetic interference: the EMIT Study.
Kozik TM; Chien G; Connolly TF; Grewal GS; Liang D; Chien W
J Am Heart Assoc; 2014 Apr; 3(2):e000746. PubMed ID: 24721802
[TBL] [Abstract][Full Text] [Related]
19. Subcutaneous Implantable Cardioverter-Defibrillator Shocks After Left Ventricular Assist Device Implantation.
Pfeffer TJ; König T; Duncker D; Michalski R; Hohmann S; Oswald H; Schmitto JD; Veltmann C
Circ Arrhythm Electrophysiol; 2016 Nov; 9(11):. PubMed ID: 27793958
[No Abstract] [Full Text] [Related]
20. Inappropriate implantable cardioverter-defibrillator therapy during exercise: what is the mechanism?
Vollmann D; Lüthje L; Zabel M
Heart Rhythm; 2009 May; 6(5):718-9. PubMed ID: 19303370
[No Abstract] [Full Text] [Related]
[Next] [New Search]
